立体定向影像引导放疗用于临床早期非小细胞肺癌:多机构长期报告
多机构回顾性分析701例接受SBRT的早期NSCLC患者,67%有组织学确诊;3年和5年OS分别为83.8%和60.6%,CSS为93.1%和86.7%,DFS为69%和45.5%;活检与未活检队列的生存和复发无统计学显著差异。
要点
- 临床诊断未活检的早期NSCLC患者接受SBRT,生存与复发结局与活检确诊者相似。
- 多学科综合临床和影像评估对未活检患者的管理至关重要。
- SBRT在经适当选择的临床诊断早期肺癌患者中有效。
核心结论
- 对临床诊断的肺癌,SBRT在适当选择的患者中有效,结局与病理诊断者相似。
研究设计与样本
- 多机构回顾性数据库分析,纳入欧洲、加拿大和美国的701例接受SBRT的NSCLC患者,要求至少2年全面随访,比较活检与未活检队列。
主要发现
- 701例中67%有组织学确诊;3年和5年OS分别为83.8%和60.6%,CSS分别为93.1%和86.7%,DFS分别为69%和45.5%。
- 3年和5年局部复发率分别为6.4%和10.5%,区域复发率分别为9.3%和14.3%,远处转移率分别为14.3%和19.7%。
- 活检与未活检队列在生存结局或复发方面无统计学显著差异。
临床怎么用
- 对于因合并症严重无法活检的早期NSCLC患者,可在多学科综合临床和影像评估后考虑SBRT。
- 未活检患者接受SBRT的结局与活检确诊者相似,支持在适当选择患者中采用临床诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Early stage lung cancer is treated with stereotactic body radiation therapy (SBRT) in patients who are unable or unwilling to undergo surgical resection. Some patients' comorbidities are so severe that they are unable to even undergo a biopsy. A clinical diagnosis without biopsy before SBRT has been used, but there are limited data on its efficacy. METHODS AND MATERIALS: Data on patients treated with SBRT for non-small cell lung cancer, with and without tissue confirmation, were collected from multiple institutions across Europe, Canada, and the United States. Patients with a minimum of 2 years of comprehensive follow up were selected for analysis. Treatment and patient characteristics were compared. Overall survival (OS), disease-free survival (DFS), cause-specific survival (CSS), and rates of local recurrence (LR), regional recurrence (RR), and distant metastasis (DM) were calculated and analyzed. RESULTS: A total of 701 patients were identified, of which 67% had tissue confirmation of their tumors. The 3- and 5-year outcomes for OS, CSS, and DFS were 83.8%, 93.1%, 69%, and 60.6%, 86.7%, 45.5%, respectively. The rates for LR, RR, and DM at 3 and 5 years were 6.4%, 9.3%, 14.3%, and 10.5%, 14.3%, 19.7%, respectively. There were no statistically significant differences in survival outcomes or recurrences between the biopsy and no-biopsy cohorts. CONCLUSIONS: SBRT for clinically diagnosed lung cancers is efficacious in appropriately selected patients, with similar outcomes as those with a pathologic diagnosis. Thorough clinical and radiographic evaluations in a multidisciplinary setting are critical to the management of these patients.
引用
- Fernandez C, Grills IS, Ye H, et al. Stereotactic Image Guided Lung Radiation Therapy for Clinical Early Stage Non-Small Cell Lung Cancer: A Long-Term Report From a Multi-Institutional Database of Patients Treated With or Without a Pathologic Diagnosis. Pract Radiat Oncol. 2019. PMID: 31837478. doi:10.1016/j.prro.2019.12.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。